ANTICOV
Identification of early treatments to prevent progression of COVID-19 to severe disease and limit disease transmission
Contact: Ricardo Strauss
The ANTICOV clinical trial responds to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes in hospitalizations that could overwhelm fragile and already overburdened health systems in low-resource settings.
More project information coming soon...
For further details please visit the AntiCov website.
